End-of-day quote
Korea S.E.
04:30:00 29/03/2024 am IST
5-day change
1st Jan Change
412
KRW
+26.77%
-.--%
-64.17%
Sejong Medical Co., Ltd. acquired 14.01% stake in Genencell Co., Ltd from Se-chan Kang for KRW 6.3 billion.
Sejong Medical Co., Ltd. (KOSDAQ:A258830) acquired 14.01% stake in Genencell Co., Ltd from Se-chan Kang for KRW 6.3 billion on October 19, 2021. Sejong Medical Co acquired 0.66 million shares of Genencell Co., Ltd in the deal. The full payment was made on October 19, 2021. The deal was funded with holding funds of Sejong Medical Co., Ltd. Genencell Co., Ltd had total assets of KRW 3.7 billion, net assets of KRW 2.5 billion, sales of KRW 150.58 million and net loss of KRW 1.8 billion million for the year ended December 31, 2020. The Board of Sejong Medical Co., Ltd. has resolved the deal on October 19, 2021.
Sejong Medical Co., Ltd. (KOSDAQ:A258830) completed the acquisition of 14.01% stake in Genencell Co., Ltd from Se-chan Kang on October 19, 2021.
Sejong Medical Co., Ltd. cancelled the transaction announced on November 7, 2022
14/05
CI
Sejong Medical Co., Ltd.(KOSDAQ:A258830) dropped from S&P Global BMI Index
18/23/18
CI
Sejong Medical Co., Ltd. announced that it has received KRW 3.5 billion in funding
31/23/31
CI
Sejong Medical Co., Ltd. announced that it has received KRW 30 billion in funding from Helixmith Co., Ltd
29/22/29
CI
Sejong Medical Co., Ltd. announced that it expects to receive KRW 3 billion in funding
26/22/26
CI
Sejong Medical Co., Ltd. announced that it expects to receive KRW 30 billion in funding from Helixmith Co., Ltd
21/22/21
CI
Doowon Science Pharmaceutical Co., Ltd. announced that it expects to receive KRW 1.16 billion in funding from Sejong Medical Co., Ltd.
12/22/12
CI
Sejong Medical Co., Ltd. agreed to acquire unknown minority stake in Doowon Science Pharmaceutical Co., Ltd. for KRW 3.5 billion.
12/22/12
CI
Sejong Medical Co., Ltd. announced that it expects to receive KRW 3.5 billion in funding
12/22/12
CI
Sejong Medical Co., Ltd. announced that it expects to receive KRW 19.99999948 billion in funding from CANARIABIO M Inc.
07/22/07
CI
Sejong Medical Co., Ltd. announced that it expects to receive KRW 19.99999948 billion in funding from CANARIABIO M Inc.
07/22/07
CI
An unknown buyer agreed to acquire 2.5679% stake in Sejong Medical Co., Ltd. from CANARIABIO M Inc. for KRW 6.3 billion.
04/22/04
CI
Sejong Medical Co., Ltd. announced that it has received KRW 80 billion in funding from CANARIABIO M Inc.
13/22/13
CI
CANARIABIO Inc. announced that it has received KRW 29.999997555 billion in funding from Sejong Medical Co., Ltd.
12/22/12
CI
CANARIABIO Inc. announced that it expects to receive KRW 19.99999837 billion in funding from Sejong Medical Co., Ltd.
04/22/04
CI
CANARIABIO M Inc. completed the acquisition of Sejong Medical Co., Ltd. (KOSDAQ : A258830) from Lee, Jae Chul & others.
30/22/30
CI
Sejong Medical Co., Ltd.(KOSDAQ:A258830) added to S&P Global BMI Index
19/22/19
CI
CANARIABIO M Inc. agreed to acquire a 40% stake in Sejong Medical Co., Ltd. (KOSDAQ : A258830) from Lee, Jae Chul for KRW 45 billion.
18/22/18
CI
Sejong Medical Co., Ltd. announced that it expects to receive KRW 50 billion in funding from CANARIABIO M Inc.
15/22/15
CI
Sejong Medical Co., Ltd. announced that it has received KRW 20 billion in funding from Meritz Securities Co., Ltd., Investment Arm
12/22/12
CI
Sejong Medical Co., Ltd. announced that it expects to receive KRW 20 billion in funding from Meritz Securities Co., Ltd., Investment Arm
29/21/29
CI
Sejong Medical Co., Ltd. acquired 14.01% stake in Genencell Co., Ltd from Se-chan Kang for KRW 6.3 billion.
20/21/20
CI
Sejong Medical Co., Ltd. announced that it has received KRW 32.49815256 billion in funding from Time Investment Co., Ltd, and other investors
17/21/17
CI
Sejong Medical Co., Ltd. announced that it expects to receive KRW 32.49815256 billion in funding from Time Investment Co., Ltd, and other investors
23/21/23
CI
Sejong Medical Co., Ltd. agreed to acquire 29.4% stake in Yozma BMTECH CO,LTD. for KRW 3.7 billion .
13/20/13
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
SEJONG MEDICAL Co.Ltd., is a Korea-based company principally engaged in the manufacturing and sale of laparoscopic surgery equipments. The Company manufactures and sells laparoscopic surgery trocar, laparoscopic bags, and laparoscopic loop. The Company distributes its products within the domestic market and to overseas markets, including Europe, Asia and North America.
More about the company
1st Jan change
Capi.
-64.17% 1.68Cr -29.57% 314.23Cr -18.39% 245.8Cr +12.41% 235.59Cr +41.48% 277.11Cr -1.23% 209.07Cr +40.00% 214.45Cr +3.80% 136.74Cr +48.11% 148.59Cr +9.44% 118.82Cr
Medical Supplies
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
marketscreener.com**derivatives**en**/dynamic-chart/**Premium**Expert**Access**Annual**Monthly**
-40% Limited Time Offer : Our subscriptions help you unlock hidden opportunities.**#000000**/services/solutions/**#fff826**#ff3000**#ffffff**
BENEFIT NOW **0**linear-gradient(180deg, rgba(42,73,76,1) 0%, rgba(28,30,51,1) 53%);**linear-gradient(180deg, rgba(255, 248, 38,1) 0%, rgba(247, 239,1) 53%);**date_fin_hors_prolongation**49**on all our subscriptions**